|
Volumn 140, Issue 6, 2008, Pages 635-643
|
Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16
|
Author keywords
Antibody dependent cellular cytotoxicity; CD20; Chronic lymphocytic leukaemia; Fc receptor; Monoclonal antibody
|
Indexed keywords
CD16 ANTIGEN;
CD20 ANTIBODY;
CD20 ANTIGEN;
CHIMERIC ANTIBODY;
COMPLEMENT;
CYCLOPHOSPHAMIDE;
FC RECEPTOR IIIA;
FLUDARABINE;
FUCOSE;
INTERLEUKIN 2;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY EMAB 6;
RITUXIMAB;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ANTIGEN EXPRESSION;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER CELL DESTRUCTION;
CANCER IMMUNOTHERAPY;
CHRONIC LYMPHATIC LEUKEMIA;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DRUG EFFICACY;
DRUG MECHANISM;
FEMALE;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL LINE;
MALE;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
AGED;
AGED, 80 AND OVER;
ANTIBODY-DEPENDENT CELL CYTOTOXICITY;
ANTIGENS, CD20;
APOPTOSIS;
DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC;
FEMALE;
HUMANS;
INTERLEUKIN-2;
KILLER CELLS, NATURAL;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
MALE;
MIDDLE AGED;
RECEPTORS, IGG;
TUMOR CELLS, CULTURED;
|
EID: 39749086517
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/j.1365-2141.2007.06974.x Document Type: Article |
Times cited : (100)
|
References (46)
|